CHD

Business Profile & Competitive Position

Church & Dwight Co., Inc. (CHD) sits in the Consumer Defensive sector and the Household & Personal Products industry. That classification means it is a staples business: it sells everyday consumables that consumers buy repeatedly regardless of the broader economic cycle. The company operates through a portfolio of branded household and personal-care products distributed in conventional retail, club, e-commerce, and professional channels.

The margin and return data give a clear read on competitive quality. CHD’s net margin is 12.0% and its return on equity (ROE) is 17.8%. A double-digit net margin in a category with fierce private-label competition is consistent with meaningful brand equity and pricing power, while an ROE near 18% points to solid capital efficiency in generating profits from shareholder equity. Those figures do not prove an unassailable moat on their own, but they do fit the profile of a company whose brands are entrenched enough to command premium shelf positioning and resist the worst margin compression in the staples space.

Financial Posture

CHD currently carries a $24.1 billion market cap, trades at a P/E of 32.6, posts a 12.0% net margin, and generates a 17.8% ROE. Its beta is 0.47, roughly half the volatility of the overall market, which is exactly what market participants expect from a defensive consumer-staples name.

A P/E above 30 is not typical for a slow-growth staple, so the market is clearly paying for quality and relative earnings stability. The combination of a low beta, above-average ROE, and consistent margin supports that premium, but it also leaves the valuation sensitive to any slowdown in organic growth, margin compression, or upward rate pressure that makes future cash flows look less valuable. The stock’s current price of $101.76 sits above its 50-day EMA of $98.20, and the RSI is 63.2—neither overbought nor oversold by conventional thresholds, but close enough to prior resistance to keep momentum in focus heading into the next report.

Macro & Geopolitical Exposure

Because CHD is classified as Household & Personal Products, its macro exposure is shaped by the economics of branded staples. Three factors are particularly relevant.

First, input costs. Laundry, cleaning, and personal-care products rely on surfactants, fragrances, resins, packaging, and freight. Any sustained increase in commodity, energy, or transportation costs flows directly into cost of goods sold and can pressure the 12.0% net margin if pricing actions lag.

Second, trade and currency. Raw materials and finished goods can cross borders, so tariffs, import duties, or a stronger U.S. dollar can affect both sourcing costs and the translation of overseas revenue. These impacts are industry-wide rather than company-specific, but they matter for a global consumer-products portfolio.

Third, regulation and private-label competition. The household-products space faces ongoing regulatory scrutiny around ingredient disclosure, chemical safety, and environmental labeling. At the same time, retailers continue to grow their private-label offerings, which can pressure volume or force higher promotional spending. In a defensive sector, demand itself is relatively stable; the real macro battle is over pricing power, sourcing efficiency, and shelf share.

Recent Developments

The most recent news cluster centers on CHD’s Q2 2026 earnings call on July 31, 2026. According to the GuruFocus recap of that call, the company reported an organic sales surge of 5.8% and raised its full-year outlook. The same day, Seeking Alpha published the full Q2 2026 earnings call transcript, and MarketBeat published its own highlight reel of the quarter.

More recently, on August 7, 2026, Defenseworld.net ran a head-to-head comparison of Church & Dwight and Reynolds Consumer Products (REYN), framing the two within the broader consumer-defensive peer set. That piece is useful context, but it is a relative-valuation comparison; it does not change the raw operational numbers CHD just reported.

The Q2 report’s two standout facts—the 5.8% organic-sales growth and the raised full-year guidance—are the items most likely to be repriced into forward estimates. Analysts and investors will compare those qualitative beats against the consensus EPS estimate of $0.90 for the next report on October 30, 2026.

Earnings Behavior & Post-Earnings Drift

Over the last eight reported quarters, CHD has beaten earnings expectations 6 out of 8 times (a 75% beat rate when expressed as a fraction, or 6/8), with an average earnings surprise of 5.2%. The average five-day post-earnings move over that span has been +1.32%, classified as an “up” drift direction. On the surface, that looks like a textbook positive post-earnings drift.

The more interesting story is what happened beneath the headline. In the most recent four quarters, the relationship between the headline surprise and the subsequent price move has been weak:

• July 31, 2026: EPS of $0.89 missed the $0.896 estimate by 0.7%. The stock still rose 1.21% the next day and 4.48% over the next five days.
• May 1, 2026: EPS of $0.95 beat the $0.931 estimate by 2.0%. The stock fell 3.26% the next day and 2.69% over the following five days.
• January 30, 2026: EPS of $0.86 beat the $0.836 estimate by 2.9%. The stock rose 1.13% the next day and 4.45% over five days.
• October 31, 2025: EPS of $0.81 crushed the $0.736 estimate by 10.1%. The stock fell 1.61% the next day and 0.95% over the following five days.

This is the real disconnect: a beat does not reliably produce a pop-and-hold, and a miss does not reliably produce a drop. The October 2025 10.1% beat was the largest surprise of the four, yet the stock drifted lower. The July 2026 miss coincided with the strongest five-day rally, likely because the guidance and full-year outlook were the items traders repriced, not the narrow EPS print. The takeaway for earnings analysis is that CHD’s reaction depends on what changes in forward guidance, what the unofficial consensus had already priced in, and how valuation demanded the result. With the stock at $101.76 and an above-market P/E of 32.6, the room for “good news” to shock the price higher may be smaller than the raw beat rate implies.

For a deeper dive, compare these numbers against the full institutional verdict on CHD, including sell-side ratings, estimate-revision trends, and target-price dispersion, to see how professional analysts currently weigh the company’s premium valuation against its defensive earnings profile.